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Determining optimal conditions for the production of well diffracting crystals is
a key step in every biocrystallography project. Here, a microfluidic device is
described that enables the production of crystals by counter-diffusion and their
direct on-chip analysis by serial crystallography at room temperature. Nine ‘non-
model’ and diverse biomacromolecules, including seven soluble proteins, a
membrane protein and an RNA duplex, were crystallized and treated on-chip
with a variety of standard techniques including micro-seeding, crystal soaking
with ligands and crystal detection by fluorescence. Furthermore, the crystal
structures of four proteins and an RNA were determined based on serial data
collected on four synchrotron beamlines, demonstrating the general applic-
ability of this multipurpose chip concept.
1. Introduction
Crystallography plays a central role in contemporary biology
because it enables the visualization of the 3D architecture of
biological macromolecules, which provides insights into their
cellular functions and partnerships on the atomic scale (Giege´
& Sauter, 2010; Jaskolski et al., 2014). Over the past two
decades, the advent of structural genomics and associated
high-throughput (HTP) technologies (Vincentelli et al., 2003;
Pusey et al., 2005), together with dramatic improvements in
experimental setups and the computational environment at
synchrotron facilities (Terwilliger et al., 2009; Owen et al.,
2016), have revolutionized the field and led to a torrent of new
crystal structures. This productivity boost is clear from the
number of structures deposited in the Protein Data Bank
(PDB), which recently exceeded 150 000 entries.
In spite of such advances, the time-consuming and costly
mapping of reagents and phase space to identify conditions
that yield diffraction-quality crystals from a limited amount of
the macromolecule remains a bottleneck in crystallographic
studies (McPherson & Gavira, 2014; Luft et al., 2014; Giege´,
2017). This process generally involves a trial-and-error
sampling of chemical and physical space by screening hundreds
of different cocktails composed of buffers at different pH
values, various crystallants (salts, alcohols and polymers) and
temperature to find at least one appropriate solvent and the
right supersaturation conditions. The miniaturization of crys-
tallization assays in microplates with drop volumes of 0.1–1 ml
(typically containing 1–10 mg of the macromolecule) and
automation of the screening procedure have made this task
considerably more efficient, making it possible to successfully
conduct a project with only a few milligrams of pure sample
(Sauter et al., 2012).
With the introduction of the first microfluidic systems
dedicated to HTP screening 15 years ago, the sample volume
required for a single experiment was reduced by another order
of magnitude, down to a few nanolitres (Hansen et al., 2002;
Zheng et al., 2003). Indeed, microfluidics was immediately
regarded as a major breakthrough, especially for biochemists
dealing with samples that are difficult to purify in large
quantities, such as macromolecules from higher eukaryotes,
large biological assemblies and membrane proteins (Hansen &
Quake, 2003; van der Woerd et al., 2003). However, despite
their potential, microfluidic technologies have not yet been
massively adopted by the global community for crystal growth,
as illustrated by the limited number of PDB entries (only
about 30 as of March 2019) that specifically cite the use of
microfluidic systems. This can be partly explained by the cost
of these microsystems and their associated equipment, but
also by the difficulty in successfully extracting fragile crystals
from the chips or the requirement to reproduce them using
conventional crystallization methods before they can be
subjected to crystallographic analysis.
To expand the functionality and attractiveness of micro-
chips beyond crystallization and HTP screening, several teams
have explored the possibility of analyzing crystals directly in
their microfluidic environment (Yadav et al., 2005; Ng et al.,
2008; Sauter et al., 2007; Dhouib et al., 2009; Emamzadah et al.,
2009; Hansen et al., 2006; Stojanoff et al., 2011). Various
geometries and materials have been tested and have led to
promising results in terms of data collection, anomalous
phasing or time-resolved applications (Pinker et al., 2013;
Khvostichenko et al., 2014; Perry et al., 2013, 2014). The
difficulty of cryopreserving crystals to protect them from
radiation damage inside chips, owing to the wide flat surfaces
of the device causing vapor condensation and ice formation in
the cryojet, was first perceived as an obstacle. However, the
recent revival of multi-crystal data-collection techniques at
room temperature by the X-ray free-electron laser (XFEL)
community has changed the paradigm and popularized serial
crystallography (Chapman et al., 2011; Stellato et al., 2014;
Ayyer et al., 2015). In this context, microfluidic systems
provide promising solutions to prepare, handle and analyze
crystals at both synchrotron beamlines and XFELs (Heymann
et al., 2014; Sui et al., 2016).
In this report, we describe a versatile and low-cost micro-
fluidic chip for crystal production and characterization. This
chip was initially designed to miniaturize and facilitate the
identification of crystal-growth conditions using the counter-
diffusion method and its efficient self-optimizing process
(Dhouib et al., 2009; Pinker et al., 2013). The latest version of
the chip design, called ChipX3, incorporates several
improvements in terms of sample injection, reservoir loading
and design to allow low-cost manufacturing by injection
molding. With ChipX3, we demonstrate that crystals can (i) be
easily produced by seeding, (ii) be soaked in situ with ligands
or (iii) be visualized by fluorescence imaging. In addition, the
chip provides a stable platform for crystal storage, handling,
shipment and in situ analysis by serial crystallography. We
illustrate a range of applications for ChipX3 by the crystal-
lization of seven soluble proteins, a membrane protein and an
RNA duplex, as well as the structure determination of five
‘non-model’ macromolecules at room temperature using data
collected on four beamlines at three different synchrotron
sites. This lab-on-a-chip approach simplifies and efficiently
miniaturizes the crystallographic structure-determination
process, from the sample to its 3D structure, in a single device.
It offers a user-friendly, cost-effective solution for routine
biocrystallographic investigations at room temperature.
2. Materials and methods
2.1. Biomacromolecules, biochemicals and chemicals
The recombinant proteins used in this work include
protease 1 from Pyrococcus horikoshii (PhP1), the llama
nanobody PorM_02 (Nb02), a lipase from Thermomyces
lanuginosus (Lip; provided by Macrocrystal Oy, Finland), the
CCA-adding enzyme from the psychrophilic bacterium
Planococcus halocryophilus (CCA), the TonB-dependent
heme/hemoglobin outer membrane transporter (OMT) ShuA
from the pathogen Shigella dysenteriae (OMT ShuA), the
human mitochondrial aspartyl-tRNA synthetase (hmDRS)
and aspartyl-tRNA synthetase 1 from the bacterium Thermus
thermophilus (ttDRS), which were purified as described
previously (Engilberge et al., 2018; Duhoo et al., 2017; Ernst et
al., 2018; Brillet et al., 2009; Sauter et al., 2015; Zhu et al., 2001).
Horse hemoglobin was purchased from Sigma. The nine-base-
pair RNA duplex [r(CGUGAUCG)dC]2 was prepared as
described by Masquida et al. (1999). Stock concentrations and
storage buffers are indicated in Table 1.
To facilitate the detection of CCA crystals by trace fluor-
escent labeling (TFL; Pusey et al., 2015), the protein was
fluorescently labeled with carboxyrhodamine-succinimidyl
ester (Invitrogen, catalog No. C6157) as described by de Wijn
et al. (2018). The labeled protein solution was stored at 277 K
and mixed with the protein stock solution just before
preparing crystallization assays as a fraction corresponding to
less than 1% of the total protein stock. This solution will be
referred to as ‘CCA-TFL’.
The nonhydrolyzable analog of cytidyl triphosphate (CTP)
that was soaked into the CCA crystals, cytidine-50-[(,)-
methyleno]triphosphate (CMPcPP), was purchased from Jena
Bioscience (catalog No. NU-438). The lanthanide complex Tb-
Xo4 (commercial name Crystallophore) used to crystallize
PhP1 was synthesized as described by Engilberge et al. (2017).
2.2. ChipX3 manufacturing
ChipX3 devices were designed at IBMC, Strasbourg, France
in collaboration with Synchrotron SOLEIL, Saint-Aubin,
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France and were manufactured by MicroLIQUID, Arraste,
Spain. The fluidic layer (thickness 1 mm) was produced in
cyclic olefin copolymer (COC; TOPAS 5013F-04) by injection
molding. Channels and reservoirs were sealed with a second
layer of COC (thickness 100 mm). The bonding process was
carried out at 398 K and a pressure of 500 kPa. The straight
section of the microfluidic channels is 4 cm long with a cross-
section of 80  80 mm, to give a volume of 260 nl. The reser-
voir at their extremity has a volume of 10 ml (Fig. 1).
2.3. Sample loading and crystallization
Crystallization experiments in the ChipX3 were set up in
three steps with a conventional 10 ml micropipet (Gilson) and
regular tips (StarLab). Firstly, 4–6 ml of macromolecule solu-
tion was injected into the sample inlet connecting all channels
to fill the entire arborescence up to the reservoirs. Secondly,
1 ml of paraffin oil (Fluka) was injected into the sample inlet to
isolate the channels from each other and the inlet was sealed
with CrystalClear tape (Hampton Research) to prevent
evaporation and solution movements. The third and last step
consisted of filling the reservoirs with 5 ml crystallization
solution before sealing them with CrystalClear tape. The
solutions used to set up the chips are listed in Table 1. All
experiments were incubated at 293 K, except for the RNA
duplex, which was crystallized at 310 K.
2.4. Crystallization by seeding
The condition producing the best CCA crystals (de Wijn et
al., 2018) was found using the microseed matrix screening
(MMS) method described by D’Arcy et al. (2007, 2014). Small
crystals grown by the hanging-drop method using a reservoir
consisting of 1M diammonium hydrogen phosphate, 100 mM
sodium acetate pH 4.5 (condition E8 from the commercial
screen JCSG++ from Jena Biosciences) were recovered,
vigorously resuspended, vortexed and diluted in 50 ml of the
same crystallant solution. This suspension was stored at 277 K
and is referred to as the ‘seed stock’. Protein crystallization
solutions were prepared by mixing 6 ml enzyme solution
(5.5 mg ml1), 1.5 ml seed stock (either the original or diluted
solution) and 1 ml CCA-TFL and were immediately injected
into the chip channels. Crystallization of the ttDRS enzyme in
the ChipX3 was also performed using seeds. The ‘seed stock’
suspension was prepared as described for the CCA enzyme by
crushing crystals grown by vapor diffusion in hanging drops
with a reservoir consisting of 7%(m/v) PEG 8000, 10 mM
MgCl2. ttDRS crystallization solutions were prepared as a
mixture consisting of 6.5 ml enzyme solution (19 mg ml1) and
1.5 ml seed stock, either the original or diluted solution, and
were immediately injected into the chip channels.
2.5. Crystal soaking with substrate
To soak CCA crystals grown in the ChipX3, the tape
covering the reservoirs was removed and 3 ml of 10 mM
CMPcPP solution was added to selected reservoirs (final
concentration of 3.75 mM) before sealing them again. This
step was performed a week before data collection to ensure
good diffusion along the microfluidic channels and in an
attempt to maximize site occupancy in the crystals.
2.6. X-ray data collection and analysis
Diffraction data were collected either (i) on beamline PXII
(Fuchs et al., 2014) equipped with a PILATUS 6M detector or
beamline PXIII (Bingel-Erlenmeyer et al., 2011) equipped
with a MAR CCD or a PILATUS 2M-F detector at the Swiss
Light Source (SLS), Villigen, Switzerland, (ii) on the
PROXIMA-2A (PX2A) beamline (Duran et al., 2013)
equipped with an EIGER X 9M detector at SOLEIL, Saint-
Aubin, France or (iii) on beamline ID30B (McCarthy et al.,
2018) equipped with a PILATUS3 6M detector at the ESRF,
Grenoble, France.
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Table 1
Biomolecules and crystallization conditions.
Biological source
No. of residues/
molecular mass
(kDa)
Biomolecule
concentration
(mg ml1) Biomolecule buffer solution Crystallant solution
CCA-adding
enzyme
Planococcus
halocryophilus
420/48.5 5.5 50 mM Tris–HCl pH 7.5,
200 mM NaCl, 5 mM MgCl2
30%(m/v) PEG 3350, 200 mM sodium formate
pH 6.6
Nanobody 02 Llama 129/14.5 13.8 10 mM HEPES–NaOH pH 7.25,
150 mM NaCl
20%(m/v) PEG 3000, 0.1M trisodium citrate pH 5.5
Protease 1 Pyrococcus
horikoshii
6  166/111.6 7.4 20 mM Tris–HCl pH 7.5,
10 mM Xo4
3.4M malonate pH 7.5
Lipase Thermomyces
lanuginosus
269/29.3 30 25 mM HEPES–NaOH pH 7.5 0.3M sodium/potasssium phosphate, 50 mM
sodium acetate pH 4.5
Aspartyl-tRNA
synthetase 1
Thermus
thermophilus
2  580/132 19 50 mM Tris–HCl pH 7.2,
1 mM EDTA, 1 mM DTT
10%(m/v) PEG 8000
Mitochondrial
aspartyl-tRNA
synthetase
Homo sapiens 2  630/140 30 50 mM HEPES–NaOH pH 7.5,
150 mM NaCl, 10% glycerol,
1 mM DTT
100 mM Tris–HCl pH 7.0, 40%(m/v) PEG 3350,
0.2M sodium thiocyanate
OMT ShuA Shigella
dysenteriae
632/69.5 20 10 mM Tris–HCl pH 8.0,
1.4% -d-octyl-glucoside
0.1M sodium acetate, 20%(m/v) PEG 400,
15%(m/v) PEG 4000, 10%(m/v) PEG 8000 pH 5.0
RNA duplex Synthetic 2  9/5.8 10 10 mM sodium cacodylate
pH 6.0, 5 mM MgCl2
2.6M ammonium sulfate, 50 mM sodium
cacodylate pH 6.0, 5 mM MgSO4, 1 mM
spermine
Hemoglobin Equus caballus 574/62 20 50 mM potassium
phosphate pH 7.5
3.3M ammonium sulfate, 50 mM potassium
phosphate pH 7.5
All serial data collections were performed at room
temperature (T = 293–298 K) on crystals inside ChipX3, owing
to the reduced scattering background of the chip (Pinker et al.,
2013). In most cases a dedicated 3D-printed holder mounted
on a standard goniometer (see Fig. 5 and Supplementary Fig.
S2) was used for data collections. To collect the widest possible
rotation angle for each crystal in ChipX3, the channel
containing the crystal was aligned with the rotation axis of the
goniometer. Crystal alignment was performed either by stan-
dard low-dose grid screening at SLS and SOLEIL, or by a one-
click procedure at ESRF as described by McCarthy et al.
(2018). To avoid collisions with the surrounding equipment
(beamstop and collimator), we typically collected 30 rota-
tions per crystal or crystal sector between goniometer posi-
tions 30 and +30 (where 0 corresponding to the channels
being perpendicular to the X-ray beam). Two data-collection
strategies were used to obtain complete data: either merging
several partial data sets (sweeps) from the same crystal (one
orientation and a wide rotation range) or merging several data
sets from different crystals (several orientations and a smaller
rotation range per crystal). Table 2 provides details of data
collection and processing.
Partial data sets were individually processed with XDS
(Kabsch, 2010). When their number did not exceed ten, they
were manually merged with XSCALE to find the best
combination and determine the appropriate resolution range.
In the case of the PhP1 enzyme, ccCluster (Santoni et al., 2017)
was used to determine the best partial data sets to merge
among the 35 available. For all remaining steps, the PHENIX
package was used (Adams et al., 2010). Phases were deter-
mined by molecular replacement using the following struc-
tures: PDB entries 1miv (Li et al., 2002) for CCA, 5lmw
(Duhoo et al., 2017) for Nb02, 1g2i (Du et al., 2000) for PhP1,
4gwl (P. K. Shukla, M. Sinha, J. Mukherjee, M. N. Gupta, P.
Kaur, S. Sharma & T. P. Singh, unpublished work) for Lip and
485d (Masquida et al., 1999) for the RNA. The latter crystals
(space group H3) presented translational pseudo-symmetry
owing to the intrinsic symmetry of the duplex and merohedral
twinning (twin fraction 0.21–0.39). Hence, the structure was
refined using the twin law h, k  h, l. All structures were
built and refined with Coot and phenix.refine (Emsley &
Cowtan, 2004; Adams et al., 2010).
3. Results and discussion
3.1. ChipX3 design and setup
ChipX3 was designed to perform counter-diffusion (CD)
experiments and take advantage of convection-free conditions
(a prerequisite of CD) in channels of small cross-section
(width 80 mm, depth 80 mm) to enable the creation of crys-
tallant concentration gradients by pure diffusion [Fig. 1(a)].
The channels, with a length of 4 cm, allow a broad screening
of supersaturation states, as does conventional CD in micro-
capillaries (Garcı´a-Ruiz et al., 2001; Ota´lora et al., 2009).
The geometry of the sample inlet was adapted to fit stan-
dard P2/P10 micropipet tips for chip loading using standard
laboratory materials. No extra equipment (such as a pump) is
required. The standard micropipet is used to inject the solu-
tion into the fluidic system. The branching channel config-
uration [Fig. 1(b)] allows the simultaneous loading of the eight
channels in a single manipulation, thus limiting the loading
time and solution dead volumes. Note that in the case of
membrane-protein samples containing a detergent (such as
ShuA in this work), solutions enter and fill the channels
spontaneously owing to capillary action and the native wett-
ability of the COC material. Labels embossed along the
channels facilitate crystal location and
grid mapping on synchrotron beamlines
[Fig. 1(c)].
Once the channels have been filled
with the macromolecule solution and
the inlet closed with tape, crystallant
solutions are deposited in the reservoirs
[Fig. 1(d)]. The setup is fully compatible
with viscous solutions such as the PEG
mixtures used in CD screens (Gonza´lez-
Ramı´rez et al., 2017). The funnel-like
channel shape has been optimized to
facilitate the contact between the crys-
tallization and macromolecule solutions
and to avoid trapping air bubbles, which
could prevent the diffusion process. 1 ml
low-gelling temperature agarose solution
at 1%(w/v) can optionally be deposited
in the funnel prior to the crystallization
cocktail to constitute a physical buffer
at the entry to the channels that stabi-
lizes the diffusion interface.
The loading procedure of ChipX3 is
fast and straightforward. Setting up a
research papers
IUCrJ (2019). 6, 454–464 Raphae¨l de Wijn et al.  Microfluidic device for serial crystallography 457
Figure 1
ChipX3 setup. (a) Schematic view of the chip, which has the dimensions of a microscope slide (75
25 mm) and eight channels with a straight segment of 4 cm and a cross-section of 80 80 mm. Close-
up views are shown of (b) the inlet for the biomacromolecule solution, (c) the channels and labels,
and (d) the end of the channel and the crystallant reservoir.
chip with eight different conditions takes less than 5 min even
for untrained experimenters, as attested by numerous assays
performed in the five laboratories involved in this work and by
the many participants of crystallization workshops [FEBS
courses in 2014–2018 in Nove´ Hrady, Czech Republic; Inter-
national School of Biological Crystallization (ISBC) 2015–
2017 in Granada, Spain].
3.2. Crystallization in ChipX3
After a prototyping phase of small batches made by
hot embossing (Pinker et al., 2013), a 3D mold was machined
with the new ChipX3 specifications to produce a larger
batch by injection molding. This enabled validation of the
concept using real cases beyond classical model proteins such
as lysozyme or thaumatin. We report here on eight proteins of
different sizes and sources (from bacteria to human) and an
RNA oligomer (Table 1) crystallized in ChipX3. Crystal-
lization conditions were adapted from those initially used in
vapor diffusion or batch crystallization: while the biomacro-
molecule concentration was kept unchanged, the crystallant
concentration was increased by a factor of 1.5–2, as recom-
mended by Ota´lora et al. (2009). Representative examples
ranging from small microcrystals to large crystals filling a
portion of the channel are shown in Fig. 2. Typical counter-
diffusion patterns can be observed along the concentration
gradient, with microcrystalline material close to the reservoirs
where supersaturation is maximal and larger crystals towards
research papers
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Table 2
Data-collection and refinement statistics.
Values in parentheses correspond to the high resolution range.
CCA-adding enzyme
CCA-adding enzyme
+ CMPcPP Nanobody 02 Protease 1 Lipase RNA duplex
X-ray beamline PXIII, SLS PXII, SLS PX2A, SOLEIL PXIII, SLS ID30B, ESRF PXIII, SLS
Wavelength (A˚) 1.000 1.000 0.826 1.240 0.976 0.826
Temperature (K) 293 293 293 293 293 293
Detector PILATUS 2M-F PILATUS 6M EIGER PILATUS 2M-F PILATUS3 6M MAR CCD
Crystal-to-detector distance (mm) 300 400 154 150/200 502 200
Crystals collected 6 14 9 1/11 14 3
Crystals selected 5 5 1 8 2 3
Rotation range per image () 0.1 0.2 0.1 0.2 0.1 2–3
No. of images selected 1000 540 500 1300 600 80
Total rotation range () 100 108 50 260 60 155
Exposure time per image (s) 0.1 0.1 0.1 0.1 0.02 1–2
Space group P43212 P43212 P43212 P41212 P61 R3
a, c (A˚) 71.5, 293.8 71.4, 293.6 66.7, 91.8 125.6, 133.9 142.6, 80.7 40.0, 69.1
Solvent content (%) 68.3 67.8 65.0 74.0 68.6 54.7
Mean mosaicity () 0.04 0.04 0.07 0.04 0.03 0.15
Resolution range (A˚) 46–2.54
(2.60–2.54)
48–2.30
(2.40–2.30)
50–2.10
(2.18–2.10)
50–2.15
(2.21–2.15)
49.06–2.50
(2.60–2.50)
23–1.55
(1.59–1.55)
Total No. of reflections 176105 (9374) 232642 (32937) 45307 (4574) 1095436 (85346) 102820 (11312) 21681 (605)
No. of unique reflections 23922 (1598) 34862 (4066) 12281 (1196) 57690 (4522) 31982 (3668) 5485 (304)
Completeness (%) 90.6 (84.6) 99.5 (100.0) 97.2 (98.3) 98.5 (99.6) 98.5 (98.9) 91.5 (69.7)
Multiplicity 7.5 (6.0) 6.7 (8.1) 3.7 (3.8) 19.0 (18.9) 3.2 (3.1) 3.9 (2.0)
hI/(I)i 8.1 (1.3) 6.9 (0.7) 11.3 (1.8) 12.0 (1.4) 6.3 (0.8) 6.1 (1.8)
Rmeas (%) 18.9 (126.0) 18.0 (231.2) 7.5 (84.7) 17.4 (206.4) 8.6 (86.8) 17.9 (45.6)
CC1/2 (%) 98.7 (55.0) 98.7 (46.9) 99.7 (73.5) 99.7 (69.4) 99.4 (49.4) 98.8 (75.5)
B factor from Wilson plot (A˚2) 57.4 60.6 45.2 50.8 63.3 23.6
Reflections in working/test sets 23583/1180 34840/3405 11053/1228 57659/5758 31516/1573 5484/382
Final Rwork/Rfree (%) 18.8/21.4 20.0/22.9 16.9/21.1 16.2/18.4 17.2/19.9 19.2/22.3
No. of non-H atoms
Total 2998 3028 970 4017 4446 390
Protein 2989 2989 947 3921 4404 342
Solvent 9 10 23 96 47 43
Ligand 0 29 0 0 33 0
Ion 0 0 0 0 2 5
R.m.s.d., bonds (A˚) 0.009 0.010 0.008 0.012 0.004 0.004
R.m.s.d., angles () 1.23 1.22 0.897 1.43 1.08 0.680
Average B factors (A˚2)
Overall 60.1 62.6 53.8 57.1 83.8 17.8
Biomolecule 60.1 60.1 53.8 57.1 82.9 17.6
Solvent 52.7 55.5 50.9 56.1 62.6 15.1
Ramachandran plot regions (%)
Most favored 98.1 97.2 95.8 98.4 96.6
Allowed 1.9 2.8 4.2 1.6 3.2
PDB code 6ibp 6q52 6gzp 6q3t 6hw1 6ibq
PDB code at 100 K† 6qy6 6qxn 5lmw 6hf6 4zgb 485d
R.m.s. distance (A˚2)/Vc (%)† 0.79/5.0 0.83/3.8 0.79/6.6 0.47/4.3 1.0/3.9 0.40/2.7
† Structures solved at room temperature (this work) are compared with equivalent structures determined at cryogenic temperatures (100 K). R.m.s. distances are calculated taking into
account all biomolecule atoms and Vc quantifies the increase in the unit-cell volume (Vc) at room temperature.
the other extremity of the channels (see Supplementary
Fig. S1).
Crystals appeared after a few hours or days and could be
visualized under polarized light. To facilitate the detection of
small crystals, we exploited different fluorescence approaches
such as classical UV excitation (Meyer et al., 2015), the
fluorescent lanthanide compound Tb-Xo4 developed by
Engilberge et al. (2017) and trace fluorescent labeling (TFL) as
developed by Pusey et al. (2015). All three approaches were
compatible with ChipX3, but the Tb-Xo4 molecule and TFL
gave a much brighter signal (Fig. 3). Fluorescence has the
advantage of rapidly localizing samples in the channels and
may be used in the future to automate and speed up serial
analysis.
3.3. Advanced crystallogenesis strategies
In addition to providing an efficient screening of super-
saturation conditions, the CD process has other practical
benefits, including the possibility of diffusing anomalous
scatterers into pregrown crystals for phasing, or cryopro-
tecting with compounds such as glycerol (Gavira et al., 2002;
Ng et al., 2003). In a previous study, we demonstrated the
feasibility of on-chip SAD phasing at room temperature using
crystals soaked by CD with a lanthanide complex (Pinker et
al., 2013). Along the same lines, CMPcPP, a nonhydrolyzable
analog of CTP, which is a substrate of CCA-adding enzymes,
was added to the reservoirs once CCA crystals had grown and
one week before the synchrotron session. The resulting X-ray
structures confirmed that the crystals were derivatized by
smooth diffusion without any sign of damage (Figs. 4 and 6).
Microseeding can also be used together with CD crystal-
lization (Bergfors, 2003; Gavira et al., 2011) to bypass the
nucleation step and promote rapid crystal growth. Hence,
CCA and ttDRS crystals were grown by a combination of CD
and seeding. Microseeds were added to the protein solution
just before it was injected into the chips and the first crystals
appeared in the channels after a few days. Seeding proved
to be an effective way to trigger rapid and abundant crystal
production, which is of particular interest for serial analysis.
We also used a new nucleant called crystallophore or Xo4
(Engilberge et al., 2018) in the case of the protein PhP1, for
which the crystallization conditions (Table 1) were determined
only in the presence of this terbium complex. Tb-Xo4 was
added to the protein solution before filling the channels. It
triggered the nucleation and the growth of large PhP1 crystals,
which completely filled the available volume. An added value
for macromolecules crystallized in the presence of Xo4 is the
strong luminescence when illuminated by UV light (see Fig. 3).
3.4. Serial crystal analysis inside ChipX3
The ChipX3 was designed for in situ characterization. Its
overall thickness was optimized to give a good compromise
between material rigidity and X-ray absorption/scattering
(Pinker et al., 2013). The COC material produces a char-
acteristic diffuse scattering ring [Fig. 5(c)] in the resolution
range 4–6 A˚ (see also Fig. 4 in Dhouib et al., 2009 and Fig. 10.4
in Martiel et al., 2018), which hardly affects data processing
and quality. During data collection, the chip is oriented with its
thickest layer facing the direct beam and the thinnest face
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Figure 2
Examples of crystals obtained in ChipX3. Crystals were grown as
described in Table 1. (a) CCA, (b) PhP1, (c, d) Nb02 before (c) and after
(d) data collection, with the X-ray beam footprint, (e) lipase, ( f ) ttDRS,
(g) hmDRS, (h) OMT ShuA, (i) oligo RNA duplex and (j) hemoglobin.
The scale bar is 0.1 mm in length.
behind the crystal to minimize the attenuation of the diffrac-
tion signal (Fig. 5). Labels embossed along the channels
enable the easy localization of crystals before analysis, with a
view to future automation of the procedure on synchrotron
beamlines. The chip can also be positioned in the beam using a
plate gripper, as illustrated in Supplementary Fig. S3. To avoid
intervention from beamline staff to mount/unmount the
gripper, we developed a light chip holder that can be directly
attached to a standard goniometer. This chip holder is
manufactured by 3D printing (Fig. 5, Supplementary Fig. S2)
and integrates a standard metal base (B5, SPINE-style;
MiTeGen) that is in contact with the goniometer magnet. The
holder can be used with any flat device of microscope-slide
dimensions on synchrotron beamlines and laboratory-based
instruments. The 3D description file for printing this device is
provided as supporting information.
To illustrate the general applicability of on-chip serial
crystallography at room temperature, we present the results of
structure determination in the 1.5–2.5 A˚ resolution range of
four proteins (CCA, Lip, Nb02 and PhP1) and an RNA
(Table 2, Figs. 5 and 6). Hemoglobin crystals also yielded
complete data to 2.8 A˚ resolution (data not shown), whereas
the microcrystals of the aspartyl-tRNA synthetases and OMT
ShuA only diffracted to low resolution and could not be used
for structure determination without further optimization.
The data collections were carried out on series of crystals
and their parameters were adapted for crystal size and sensi-
tivity to radiation damage. When collecting several paths from
the same crystal signs of radiation damage could clearly be
seen [see Fig. 2(d)], accompanied by the formation of gas
bubbles as described by Meents et al. (2010) and by the
deterioration of data-collection statistics (data not shown).
Note that performing in situ analysis, i.e. without direct
handling of the crystals, is a guarantee that their genuine
diffraction properties have been preserved. Comparative
tests on thaumatin or lipase crystals in ChipX3 sent by
regular postal mail or carried to the synchrotron by
experimenters did not show significant differences (results
not shown), indicating that the chip is a stable and robust
container for crystal storage and transport.
Final crystal structures were obtained
either from a single large crystal and
two wedges (Nb02) or from combining
partial data sets from several individual
crystals (RNA, CCA, Lip and PhP1). In
the latter case, the use of ccCluster
considerably facilitated the choice of
partial data sets to be merged. The
comparison of these structures with
equivalent structures solved at cryo-
genic temperatures only showed small
differences (see the r.m.s. distances in
Table 2), although the unit-cell volumes
were significantly larger (2.7–6.6%) at
room temperature than at 100 K
because of crystal shrinkage occurring
during cryocooling.
The high sensitivity and low back-
ground of the latest hybrid pixel detec-
tors (HPDs) compared with CCD
detectors (Pinker et al., 2013), and the
very short analysis time (seconds) of the
largest wedge of reciprocal space from
single crystals are crucial to outrun
radiation damage for room-temperature
data collection. The analysis in shutter-
less mode also limits systematic errors in
crystal orientation and thus improves
the data quality. For example, the
highest apparent mosaicity of the RNA
crystals (see Table 2), which were
analyzed at an early stage of this work
with a MAR CCD detector, is a direct
symptom of the data-collection strate-
gies used before the advent of HPDs. In
the future, the widespread integration
of HPD technology at synchrotron sites
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Figure 3
Crystal detection in ChipX3 by fluorescence. (a, b) CCA crystals grown as described in Table 1 with
0.6% CCA-TFL; (c, d) PhP1 crystals grown as described in Table 1 with 10 mM Tb-Xo4. (a, c)
Crystals illuminated with white light. (b) Crystal illuminated with a 520 nm light source and image
taken with a low-pass filter at 550 nm (LP550); inset, structure of carboxyrhodamine-succinimidyl
ester. (d) Crystal illuminated with a 280–380 nm UV source; inset, structure of Tb-Xo4. The scale
bar is 0.1 mm in length.
and on laboratory-based X-ray sources will undoubtedly
facilitate the development of serial crystallography.
The concept of serial crystallography was introduced with
XFEL sources and their extremely intense X-ray pulses that
destroy the sample upon signal emission (a process called
‘diffraction before destruction’). As a consequence, large
numbers (thousands) of micro/nanocrystals are necessary to
obtain a complete data set from series of individual still
images. The serial approach has been extended to room-
temperature data collection using synchrotron radiation.
However, with a lower beam intensity (compared with
XFELs) crystals can be used to collect more than a single
image and up to several degrees of rotation. With very stable
crystals (see Nb02 in Table 2), a single crystal may even be
sufficient to collect complete data with the help of high
symmetry and rapid analysis using HPDs. More generally, the
number of crystals that are required for structure determina-
tion will depend on their size, their symmetry and their
sensitivity to radiation damage. Most of our structures were
derived from rather small series of 6–14 crystals and the
combination of best data sets (Table 2). With highly sensitive
samples such as membrane proteins, in situ room-temperature
serial crystallography can still be carried out successfully using
several hundred crystals (Huang et al., 2015). In this context,
ChipX3 provides a convenient means to produce batches of
crystals distributed along chip channels and, in the future,
automatic crystal detection and characterization should
contribute to speeding up data collection and popularizing this
kind of serial RT analysis.
4. Conclusion
Microfluidics has demonstrated its value in terms of minia-
turization for macromolecular crystallization experiments and
HTP screening. With ChipX3, we propose a versatile tool that
integrates all of the steps of a crystallographic study on a
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Figure 4
Crystals before and after soaking in ChipX3. Images of CCA crystals
grown as described in Table 1 with 0.6% CCA-TFL. (a, b) Before soaking.
(c, d) Images taken six days after soaking with CMPcPP at a final
concentration of 3.75 mM. (a, c) White-light illumination. (b, d) Images
taken with a 520 nm light source and a low-pass filter at 550 nm (LP550).
The scale bar is 0.1 mm in length.
Figure 5
Diffraction analysis in ChipX3. (a) ChipX3 on its holder. (b) ChipX3 on
beamline PXIII at the SLS synchrotron. (c) Example of a diffraction
pattern of the CCA adding-enzyme in ChipX3 at room temperature
(exposure 0.1 s, rotation 0.2).
single device with the size of a microscope slide. The same chip
serves to produce crystals by counter-diffusion (including
seeding techniques), to soak them with ligands (for substrate
catalysis, ligand screening in fragment-based drug design or
phasing purposes) and to perform their diffraction analysis by
in situ serial crystallography. The latter step, which is carried
out on-chip at room temperature, no longer requires any
crystal handling: neither fishing, nor mounting nor cryo-
cooling. This guarantees the preservation of the intrinsic
crystal quality, with the chip being a safe means of sample
storage and transportation. ChipX3 is easy to use with stan-
dard laboratory equipment for sample loading and crystal
observation, making it cost-effective, with minimal training or
expertise required. We show the general applicability of this
lab-on-chip concept with several case studies. Sample fluor-
escent labeling, as exemplified in this work, may be exploited
to detect and center individual crystals in the X-ray beam and
to perform their characterization fully automatically. Such
microfluidic devices show great promise in the future in the
combination of serial analysis pipelines developed at
advanced X-ray sources (XFELs and synchrotrons) for
routine structure determination at temperatures close to
physiological conditions (Martin-Garcia
et al., 2016; Johansson et al., 2017).
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